Trials / Completed
CompletedNCT00527293
Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer
Partial Breast Irradiation for Patients Undergoing Breast Conservation Therapy for Early Stage Breast Cancer: A Pilot Study
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Case Comprehensive Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: This clinical trial is studying how well partial breast radiation therapy works in treating women undergoing breast-conserving therapy for early stage breast cancer.
Detailed description
OBJECTIVES: * To determine the cosmetic outcome resulting from partial breast irradiation using two different techniques. * To determine patient satisfaction with partial breast irradiation as it pertains to their overall treatment experience as measured by a questionnaire. * To determine if there are patient factors that limit a patient's suitability to receive partial breast irradiation delivered by a particular technique. * To evaluate wound healing and overall complication rate after partial breast irradiation. * To determine ipsilateral breast tumor recurrence rates and tumor bed recurrence rates. OUTLINE: Patients undergo partial breast irradiation comprising either MammoSite® brachytherapy twice daily for 5-10 days OR 3-dimensional conformal radiotherapy twice daily for 5-10 days. After completion of study therapy, patients are followed periodically for up to 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | adjuvant therapy | If chemotherapy is planned, it must begin no earlier than two weeks following completion of radiation. If chemotherapy is given first, a minimum of 2 weeks from the last cycle must elapse prior to the start of radiation. |
| RADIATION | 3-dimensional conformal radiation therapy | 3-dimensional conformal radiotherapy twice daily for 5-10 days. |
| RADIATION | brachytherapy | Patients undergo partial breast irradiation comprising either MammoSite® brachytherapy twice daily for 5-10 days |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2010-10-01
- Completion
- 2015-02-01
- First posted
- 2007-09-10
- Last updated
- 2015-08-25
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00527293. Inclusion in this directory is not an endorsement.